[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650095":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":25,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":25,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":25,"enrollmentInfo":63,"targetDuration":25,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":37,"whyStopped":25,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"New Valley University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Antiphospholipid syndrome patients with AIHA","ACTIVE_COMPARATOR","AIHA defined by:\n\n* Anemia plus hemolysis (↑LDH, ↑indirect bilirubin, ↓haptoglobin, reticulocytosis) and\n* Positive direct anti-globulin (Coombs) test , Drug induced hemolysis or other hereditary\u002Facquired non immune hemolytic anemias.",[13,14],"Diagnostic Test: Hemoglobin","Diagnostic Test: Coombs test",{"label":16,"type":10,"description":17,"interventionNames":18},"Antiphospholipid syndrome patients without AIHA","Patients without hemolysis evidence",[13,14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Hemoglobin","Blood sample",[9,16],null,{"type":21,"name":27,"description":23,"armGroupLabels":28,"otherNames":25},"Coombs test",[9,16],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Asmaa N Hussein, MD","CONTACT","01065161752","asmaanady_1010@med.nvu.edu.eg",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Al Khārjah","Kharga Oasis","72511","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],30.54653,25.45101,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Asmaa Nady Hussein","Lecturer of Internal Medicine","100650095","autoimmune-hemolytic-anemia-and-its-clinical-implication-on-antiphospholipid-syndrome-100650095",false,"NCT07743242","Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome","Inclusion Criteria:\n\n* Adults aged ≥18 years\n* Patients with anemia consistant with hemolysis.\n* Patient diagnosed with antiphospholipid syndrome.\n* Informed consent obtained\n\nExclusion Criteria:\n\n* Age less than 18 years.\n* Other causes of anemia than autoimmune hemolysis.","ALL","18 Years",{"count":64,"type":65},230,"ESTIMATED","INTERVENTIONAL",[68],"NA","AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and\u002For obstetric morbidity with persistent antiphospholipid antibodies (aPL).",[71],"Anti Phospholipid Syndrome",[73],"AIHA","2026-08-05",{"date":76,"type":77},"2026-08-10","ACTUAL",{"date":79,"type":77},"2026-06-05",{"date":81,"type":65},"2028-04-15",{"name":5,"class":6},1]